Cargando…

Genomic and transcriptomic differences in community acquired methicillin resistant Staphylococcus aureus USA300 and USA400 strains

BACKGROUND: Staphylococcus aureus is a human pathogen responsible for substantial morbidity and mortality through its ability to cause a number of human infections including bacteremia, pneumonia and soft tissue infections. Of great concern is the emergence and dissemination of methicillin–resistant...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Marcus B, Montgomery, Christopher P, Boyle-Vavra, Susan, Shatzkes, Kenneth, Maybank, Rosslyn, Frank, Bryan C, Peterson, Scott N, Daum, Robert S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630920/
https://www.ncbi.nlm.nih.gov/pubmed/25527145
http://dx.doi.org/10.1186/1471-2164-15-1145
_version_ 1782398792666972160
author Jones, Marcus B
Montgomery, Christopher P
Boyle-Vavra, Susan
Shatzkes, Kenneth
Maybank, Rosslyn
Frank, Bryan C
Peterson, Scott N
Daum, Robert S
author_facet Jones, Marcus B
Montgomery, Christopher P
Boyle-Vavra, Susan
Shatzkes, Kenneth
Maybank, Rosslyn
Frank, Bryan C
Peterson, Scott N
Daum, Robert S
author_sort Jones, Marcus B
collection PubMed
description BACKGROUND: Staphylococcus aureus is a human pathogen responsible for substantial morbidity and mortality through its ability to cause a number of human infections including bacteremia, pneumonia and soft tissue infections. Of great concern is the emergence and dissemination of methicillin–resistant Staphylococcus aureus strains (MRSA) that are resistant to nearly all β-lactams. The emergence of the USA300 MRSA genetic background among community associated S. aureus infections (CA-MRSA) in the USA was followed by the disappearance of USA400 CA-MRSA isolates. RESULTS: To gain a greater understanding of the potential fitness advantages and virulence capacity of S. aureus USA300 clones, we performed whole genome sequencing of 15 USA300 and 4 USA400 clinical isolates. A comparison of representative genomes of the USA300 and USA400 pulsotypes indicates a number of differences in mobile genome elements. We examined the in vitro gene expression profiles by microarray hybridization and the in vivo transcriptomes during lung infection in mice of a USA300 and a USA400 MRSA strain by performing complete genome qRT-PCR analysis. The unique presence and increased expression of 6 exotoxins in USA300 (12- to 600-fold) compared to USA400 may contribute to the increased virulence of USA300 clones. Importantly, we also observed the up-regulation of prophage genes in USA300 (compared with USA400) during mouse lung infection (including genes encoded by both prophages ΦSa2usa and ΦSa3usa), suggesting that these prophages may play an important role in vivo by contributing to the elevated virulence characteristic of the USA300 clone. CONCLUSIONS: We observed differences in the genetic content of USA300 and USA400 strains, as well as significant differences of in vitro and in vivo gene expression of mobile elements in a lung pneumonia model. This is the first study to document the global transcription differences between USA300 and USA400 strains during both in vitro and in vivo growth. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1471-2164-15-1145) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4630920
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46309202015-11-04 Genomic and transcriptomic differences in community acquired methicillin resistant Staphylococcus aureus USA300 and USA400 strains Jones, Marcus B Montgomery, Christopher P Boyle-Vavra, Susan Shatzkes, Kenneth Maybank, Rosslyn Frank, Bryan C Peterson, Scott N Daum, Robert S BMC Genomics Research Article BACKGROUND: Staphylococcus aureus is a human pathogen responsible for substantial morbidity and mortality through its ability to cause a number of human infections including bacteremia, pneumonia and soft tissue infections. Of great concern is the emergence and dissemination of methicillin–resistant Staphylococcus aureus strains (MRSA) that are resistant to nearly all β-lactams. The emergence of the USA300 MRSA genetic background among community associated S. aureus infections (CA-MRSA) in the USA was followed by the disappearance of USA400 CA-MRSA isolates. RESULTS: To gain a greater understanding of the potential fitness advantages and virulence capacity of S. aureus USA300 clones, we performed whole genome sequencing of 15 USA300 and 4 USA400 clinical isolates. A comparison of representative genomes of the USA300 and USA400 pulsotypes indicates a number of differences in mobile genome elements. We examined the in vitro gene expression profiles by microarray hybridization and the in vivo transcriptomes during lung infection in mice of a USA300 and a USA400 MRSA strain by performing complete genome qRT-PCR analysis. The unique presence and increased expression of 6 exotoxins in USA300 (12- to 600-fold) compared to USA400 may contribute to the increased virulence of USA300 clones. Importantly, we also observed the up-regulation of prophage genes in USA300 (compared with USA400) during mouse lung infection (including genes encoded by both prophages ΦSa2usa and ΦSa3usa), suggesting that these prophages may play an important role in vivo by contributing to the elevated virulence characteristic of the USA300 clone. CONCLUSIONS: We observed differences in the genetic content of USA300 and USA400 strains, as well as significant differences of in vitro and in vivo gene expression of mobile elements in a lung pneumonia model. This is the first study to document the global transcription differences between USA300 and USA400 strains during both in vitro and in vivo growth. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1471-2164-15-1145) contains supplementary material, which is available to authorized users. BioMed Central 2014-12-19 /pmc/articles/PMC4630920/ /pubmed/25527145 http://dx.doi.org/10.1186/1471-2164-15-1145 Text en © Jones et al.; licensee BioMed Central. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Jones, Marcus B
Montgomery, Christopher P
Boyle-Vavra, Susan
Shatzkes, Kenneth
Maybank, Rosslyn
Frank, Bryan C
Peterson, Scott N
Daum, Robert S
Genomic and transcriptomic differences in community acquired methicillin resistant Staphylococcus aureus USA300 and USA400 strains
title Genomic and transcriptomic differences in community acquired methicillin resistant Staphylococcus aureus USA300 and USA400 strains
title_full Genomic and transcriptomic differences in community acquired methicillin resistant Staphylococcus aureus USA300 and USA400 strains
title_fullStr Genomic and transcriptomic differences in community acquired methicillin resistant Staphylococcus aureus USA300 and USA400 strains
title_full_unstemmed Genomic and transcriptomic differences in community acquired methicillin resistant Staphylococcus aureus USA300 and USA400 strains
title_short Genomic and transcriptomic differences in community acquired methicillin resistant Staphylococcus aureus USA300 and USA400 strains
title_sort genomic and transcriptomic differences in community acquired methicillin resistant staphylococcus aureus usa300 and usa400 strains
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630920/
https://www.ncbi.nlm.nih.gov/pubmed/25527145
http://dx.doi.org/10.1186/1471-2164-15-1145
work_keys_str_mv AT jonesmarcusb genomicandtranscriptomicdifferencesincommunityacquiredmethicillinresistantstaphylococcusaureususa300andusa400strains
AT montgomerychristopherp genomicandtranscriptomicdifferencesincommunityacquiredmethicillinresistantstaphylococcusaureususa300andusa400strains
AT boylevavrasusan genomicandtranscriptomicdifferencesincommunityacquiredmethicillinresistantstaphylococcusaureususa300andusa400strains
AT shatzkeskenneth genomicandtranscriptomicdifferencesincommunityacquiredmethicillinresistantstaphylococcusaureususa300andusa400strains
AT maybankrosslyn genomicandtranscriptomicdifferencesincommunityacquiredmethicillinresistantstaphylococcusaureususa300andusa400strains
AT frankbryanc genomicandtranscriptomicdifferencesincommunityacquiredmethicillinresistantstaphylococcusaureususa300andusa400strains
AT petersonscottn genomicandtranscriptomicdifferencesincommunityacquiredmethicillinresistantstaphylococcusaureususa300andusa400strains
AT daumroberts genomicandtranscriptomicdifferencesincommunityacquiredmethicillinresistantstaphylococcusaureususa300andusa400strains